FORGOTTEN HISTORY: Abbott labs - The Untold Story

This Dividend King Could Be One of the Safest Stocks to Own Right Now

Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.

Barchart · Jul 20

This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio

Abbott Labs is a balance of income and growth.

Barchart · Apr 23

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors.

MarketBeat · Apr 7

S&P Futures Drop as Middle East Fears Weigh on Sentiment, Tesla and Netflix Earnings on Tap

December S&P 500 futures (ESZ23) are trending down -0.34% this morning as uncertainties lingered in the Middle East, and investors weighed the possibility of further rate hikes by the Federal Reserve while eagerly awaiting earnings results from U.S. heavyweights Tesla and Netflix.

Barchart · Oct 18, 2023

Nasdaq Futures Plunge as Disappointing Tesla and Netflix Results Weigh on Sentiment

September Nasdaq 100 E-Mini futures (NQU23) are down -0.67% this morning as disappointing earnings results from U.S. heavyweights Tesla and Netflix weighed on sentiment, while investors looked ahead to the next round of corporate earnings.

Barchart · Jul 20, 2023

Stock Index Futures Plunge on Pressure from Rising Bond Yields, Tesla Earnings on Tap

June S&P 500 futures (ESM23) are down -0.46%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.76% this morning after three major U.S. benchmark indices struggled for direction on Tuesday as investors weighed the latest batch of earnings reports and comments from two Federal Reserve officials.

Barchart · Apr 19, 2023

Stock Index Futures Slip as Bond Yields Climb, Tesla Earnings on Tap

June S&P 500 futures (ESM23) are down -0.46%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.76% this morning after three major U.S. benchmark indices struggled for direction on Tuesday as investors weighed the latest batch of earnings reports and comments from two Federal Reserve officials.

Barchart · Apr 19, 2023

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com · Jul 27, 2022

The US baby formula shortage isn’t bad luck. It was completely preventable

Shortages of vital, life-preserving goods are routine in America – and they’re the product of bad policy

The Guardian - US · Jun 13, 2022

Baby formula makers tell Biden they knew shortages would be dire

WASHINGTON — President Joe Biden defended his administration’s response to a national baby formula shortage, saying he acted as soon he became aware of the crisis in April — even as manufacturers told him Wednesday they saw it coming months earlier.

Tribune News Service · Jun 1, 2022